Cargando…
Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency based reprogramming
Pluripotent cells can be derived from various types of somatic cells by nuclear reprogramming using defined transcription factors. It is however unclear whether human cancer cells can be similarly reprogrammed and subsequently terminally differentiated with abrogation of tumorigenicity. Here, using...
Autores principales: | Zhang, Xi, Cruz, Filemon Dela, Terry, Melissa, Remotti, Fabrizio, Matushansky, Igor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3470785/ https://www.ncbi.nlm.nih.gov/pubmed/22777357 http://dx.doi.org/10.1038/onc.2012.237 |
Ejemplares similares
-
Solid Tumor Differentiation Therapy – Is It Possible?
por: Dela Cruz, Filemon, et al.
Publicado: (2012) -
Hiwi Mediated Tumorigenesis Is Associated with DNA Hypermethylation
por: Siddiqi, Sara, et al.
Publicado: (2012) -
Neural stemness unifies cell tumorigenicity and pluripotent differentiation potential
por: Zhang, Min, et al.
Publicado: (2022) -
Tumorigenic potential is restored during differentiation in fusion-reprogrammed cancer cells
por: Yao, J, et al.
Publicado: (2016) -
KLF4 N-Terminal Variance Modulates Induced Reprogramming to Pluripotency
por: Kim, Shin-Il, et al.
Publicado: (2015)